Research & Innovation - Participant Portal

Health Co-ordination Activities

H2020-HCO-2015Sub call of: H2020-HCO-2014-2015
Opening Date 30-07-2014 Deadline Date 24-02-2015 17:00:00 (Brussels local time)
Publication date 23-07-2014 Total Call Budget €29,000,000
Programme Horizon 2020
Status Closed Main Pillar Societal Challenges
OJ reference OJ C 361 of 11 December 2013

Topic: ERA-NET: Cardiovascular disease HCO-13-2015

Specific challenge: Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for 40% of deaths or 2 million deaths per year. Overall CVD is estimated to cost the EU economy almost EUR 110 billion a year, and they are also one of the leading causes of long term sickness and loss to the labour market. CVD is therefore a major health problem in every country in Europe.

Despite this overall burden, research into CVD is fragmented. In addition, few countries have specific programs dedicated to this field of research.

The challenges in the area of cardiovascular research can only be met by an effective cooperation at transnational level avoiding the duplication of efforts, ensuring the availability of critical mass, efficiently using available resources, exchanging knowledge, producing more significant results of higher quality and impact, and sharing data and infrastructures. 

Scope: Proposals should coordinate national and regional programmes for research in the area cardiovascular research by implementing a transnational call with EU co-funding resulting in grants to third parties. Moreover, proposals should also aim at the better collaboration and alignment of national programmes and activities and should provide concrete plans for decreasing fragmentation, for data sharing, for addressing hurdles for effective coordination, for involving stakeholders and relevant existing initiatives.

Proposals should demonstrate the expected impact on national and transnational programmes as well as the leverage effect on European research and competitiveness, and should plan the development of key indicators for supporting this.

Proposals should implement other joint activities including training and additional joint calls without EU co-funding.

The Commission considers that proposals requesting a contribution from the EU of a minimum of EUR 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected impact:

·         Stepping up funding of transnational collaborative research projects in the area of cardiovascular research;

·         Identification of common research priorities and research needs, also taking into account developments on the international level where relevant;

·         Establishment and/or implementation of a common strategic research agenda;

·         Development and alignment of national and regional plans;

·         Streamlined national or regional practices in organising research funding;

·         Increased interoperability of national research programmes;

·         Prioritisation of transnational research;

·         Sharing of data and knowledge;

·         Networking of infrastructures and databases;

·         Contribution to the establishment of the ERA by addressing issues related for example to administrative hurdles, IPR management and different practices regarding resource sharing.

Type of action: ERA-NET Co-fund

Please read carefully all provisions below before the preparation of your application.

1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.

2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme

3. Evaluation

3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme with the following exceptions:
- If a proposal fails to achieve the threshold for a criterion at any stage, the evaluation of the proposal will be stopped.
 

3.2 Guide to the submission and evaluation process

4. Proposal page limits and layout: Please refer to Part B of the standard proposal template.

5. Indicative timetable for evaluation and grant agreement:
Information on the outcome of one-stage evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of informing successful applicants.

6. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:

ERANET Cofund:

Specific provisions and funding rates
Standard proposal template (administrative forms and structure of technical annex)
Standard evaluation form
Annotated Model Grant Agreement
 

7. Additional provisions:

Horizon 2020 budget flexibility

Classified information


8. Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
 

Additional documents

You can download the same documents as one zip file from the call page

  • Legal basis - Specific Programme H2020 en
  • WP H2020 - 1. Introduction en
  • WP H2020 - 8. Health, demographic change and wellbeing en
  • Legal basis - Framework Programme H2020 en
  • Legal basis - Rules for Participation en
  • WP H2020 - 19. General Annexes en
  • FAQ en
  • Essential information for clinical studies en

No submission system is open for this topic.